Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May;18(5):257-272.
doi: 10.1038/s41582-022-00634-9. Epub 2022 Mar 24.

Recessive cerebellar and afferent ataxias - clinical challenges and future directions

Affiliations
Review

Recessive cerebellar and afferent ataxias - clinical challenges and future directions

Marie Beaudin et al. Nat Rev Neurol. 2022 May.

Abstract

Cerebellar and afferent ataxias present with a characteristic gait disorder that reflects cerebellar motor dysfunction and sensory loss. These disorders are a diagnostic challenge for clinicians because of the large number of acquired and inherited diseases that cause cerebellar and sensory neuron damage. Among such conditions that are recessively inherited, Friedreich ataxia and RFC1-associated cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) include the characteristic clinical, neuropathological and imaging features of ganglionopathies, a distinctive non-length-dependent type of sensory involvement. In this Review, we discuss the typical and atypical phenotypes of Friedreich ataxia and CANVAS, along with the features of other recessive ataxias that present with a ganglionopathy or polyneuropathy, with an emphasis on recently described clinical features, natural history and genotype-phenotype correlations. We review the main developments in understanding the complex pathology that affects the sensory neurons and cerebellum, which seem to be most vulnerable to disorders that affect mitochondrial function and DNA repair mechanisms. Finally, we discuss disease-modifying therapeutic advances in Friedreich ataxia, highlighting the most promising candidate molecules and lessons learned from previous clinical trials.

PubMed Disclaimer

References

    1. Amato, A. A. & Ropper, A. H. Sensory ganglionopathy. N. Engl. J. Med. 383, 1657–1662 (2020). A state-of-the-art review of acquired causes of sensory ganglionopathy. - PubMed - DOI
    1. Rossi, M. et al. The genetic nomenclature of recessive cerebellar ataxias. Mov. Disord. 33, 1056–1076 (2018). This article presents the revised nomenclature of recessive cerebellar ataxias, in which an ATX prefix is followed by the gene name. - PubMed - DOI
    1. Beaudin, M. et al. The classification of autosomal recessive cerebellar ataxias: a consensus statement from the society for research on the cerebellum and ataxias task force. Cerebellum 18, 1098–1125 (2019). A scoping systematic review of the literature on recessive cerebellar ataxias with a clinical classification and diagnostic approach. - PubMed - PMC - DOI
    1. Ruano, L., Melo, C., Silva, M. C. & Coutinho, P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 42, 174–183 (2014). - PubMed - DOI
    1. Cossee, M. et al. Evolution of the Friedreich’s ataxia trinucleotide repeat expansion: founder effect and premutations. Proc. Natl Acad. Sci. USA 94, 7452–7457 (1997). - PubMed - PMC - DOI

LinkOut - more resources